Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vanessa Blumer

Showing results (101-110 of 137) with videos related to

Pageof 14
Sort By:
Journal of the American College of Cardiology|August 11, 2024
2024 Update to the 2020 ACC/AHA Clinical Performance and Quality Measures for Adults With Heart Failure: A Report of the American Heart Association/American College of Cardiology Joint Committee on Performance Measures, Michelle M Kittleson, Khadijah Breathett, et al.
Circulation. Cardiovascular Quality and Outcomes|August 8, 2024
2024 Update to the 2020 ACC/AHA Clinical Performance and Quality Measures for Adults With Heart Failure: A Report of the American Heart Association/American College of Cardiology Joint Committee on Performance MeasuresMichelle M Kittleson, Khadijah Breathett, Boback Ziaeian, et al.
JACC. Heart Failure|October 4, 2025
Predicted Risk, Preclinical Heart Failure Measures, and Incident Heart Failure: The ARIC StudyJelani K Grant, Sui Zhang, Sadiya S Khan, et al.
The Lancet. Respiratory Medicine|May 8, 2025
Optimising trial design for cardiogenic shock: insights from the sixth Critical Care Clinical Trialists WorkshopAntoine Kimmoun, Connor O'Brien, Vanessa Blumer, et al.
Journal of the American Heart Association|October 27, 2023
Relationship of Race With Functional and Clinical Outcomes With the REHAB-HF Multidomain Physical Rehabilitation Intervention for Older Patients With Acute Heart FailureOlivia N Gilbert, Robert J Mentz, Alain G Bertoni, et al.
JACC. Heart Failure|September 12, 2021
Sacubitril/Valsartan Adherence and Postdischarge Outcomes Among Patients Hospitalized for Heart Failure With Reduced Ejection FractionAnthony P Carnicelli, Zhen Li, Melissa A Greiner, et al.
The American Journal of Cardiology|August 6, 2023
Comparative Outcomes of Sacubitril/Valsartan Use After Hospitalization for Heart Failure Among Medicare Beneficiaries Naïve to Renin-Angiotensin System InhibitorsJacob B Pierce, Vanessa Blumer, Sujung Choi, et al.
JACC. Heart Failure|July 18, 2025
Social Drivers of Health in Heart Failure Trials: An Analysis From the Heart Failure CollaboratoryErsilia M DeFilippis, Vanessa Blumer, Tracy T Makuvire, et al.
JACC. Heart Failure|May 8, 2025
Sex Differences in Diabetic Cardiomyopathy and Treatment Response to AT-001: Insights From the ARISE-HF StudyVanessa Blumer, James L Januzzi, Yuxi Liu, et al.
American Heart Journal|February 11, 2021
Rivaroxaban versus warfarin in patients with atrial fibrillation enrolled in Latin America: Insights from ROCKET AFVanessa Blumer, Manuel Rivera, Ramón Corbalán, et al.
Pageof 14

Showing results (101-110 of 137) with videos related to

Sort By:
Pageof 14
Journal of the American College of Cardiology|August 11, 2024
2024 Update to the 2020 ACC/AHA Clinical Performance and Quality Measures for Adults With Heart Failure: A Report of the American Heart Association/American College of Cardiology Joint Committee on Performance Measures, Michelle M Kittleson, Khadijah Breathett, et al.
Circulation. Cardiovascular Quality and Outcomes|August 8, 2024
2024 Update to the 2020 ACC/AHA Clinical Performance and Quality Measures for Adults With Heart Failure: A Report of the American Heart Association/American College of Cardiology Joint Committee on Performance MeasuresMichelle M Kittleson, Khadijah Breathett, Boback Ziaeian, et al.
JACC. Heart Failure|October 4, 2025
Predicted Risk, Preclinical Heart Failure Measures, and Incident Heart Failure: The ARIC StudyJelani K Grant, Sui Zhang, Sadiya S Khan, et al.
The Lancet. Respiratory Medicine|May 8, 2025
Optimising trial design for cardiogenic shock: insights from the sixth Critical Care Clinical Trialists WorkshopAntoine Kimmoun, Connor O'Brien, Vanessa Blumer, et al.
Journal of the American Heart Association|October 27, 2023
Relationship of Race With Functional and Clinical Outcomes With the REHAB-HF Multidomain Physical Rehabilitation Intervention for Older Patients With Acute Heart FailureOlivia N Gilbert, Robert J Mentz, Alain G Bertoni, et al.
JACC. Heart Failure|September 12, 2021
Sacubitril/Valsartan Adherence and Postdischarge Outcomes Among Patients Hospitalized for Heart Failure With Reduced Ejection FractionAnthony P Carnicelli, Zhen Li, Melissa A Greiner, et al.
The American Journal of Cardiology|August 6, 2023
Comparative Outcomes of Sacubitril/Valsartan Use After Hospitalization for Heart Failure Among Medicare Beneficiaries Naïve to Renin-Angiotensin System InhibitorsJacob B Pierce, Vanessa Blumer, Sujung Choi, et al.
JACC. Heart Failure|July 18, 2025
Social Drivers of Health in Heart Failure Trials: An Analysis From the Heart Failure CollaboratoryErsilia M DeFilippis, Vanessa Blumer, Tracy T Makuvire, et al.
JACC. Heart Failure|May 8, 2025
Sex Differences in Diabetic Cardiomyopathy and Treatment Response to AT-001: Insights From the ARISE-HF StudyVanessa Blumer, James L Januzzi, Yuxi Liu, et al.
American Heart Journal|February 11, 2021
Rivaroxaban versus warfarin in patients with atrial fibrillation enrolled in Latin America: Insights from ROCKET AFVanessa Blumer, Manuel Rivera, Ramón Corbalán, et al.
Pageof 14